Co-Diagnostics: Q4 Earnings Insights
Co-Diagnostics: Q4 Earnings Insights
Co-Diagnostics (NASDAQ:CODX) reported its Q4 earnings results on Thursday, March 14, 2024 at 04:01 PM.
聯合診斷（納斯達克股票代碼：CODX）於2024年3月14日星期四下午4點01分公佈了其第四季度業績。
Here's what investors need to know about the announcement.
以下是投資者需要了解的有關該公告的信息。
Earnings
收益
Co-Diagnostics missed estimated earnings by -150.0%, reporting an EPS of $-0.5 versus an estimate of $-0.2.
Co-Diagnostics報告的每股收益爲-0.5美元，未達到預期收益-150.0％，而預期爲-0.2美元。
Revenue was up $2.15 million from the same period last year.
收入比去年同期增長了215萬美元。
Past Earnings Performance
過去的收益表現
Last quarter the company beat on EPS by $0.09 which was followed by a 10.0% drop in the share price the next day.
上個季度，該公司的每股收益高出0.09美元，隨後第二天股價下跌了10.0％。
Here's a look at Co-Diagnostics's past performance:
以下是Co-Diagnostics過去的表現：
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.29 | -0.24 | -0.22 | -0.15 |
| EPS Actual | -0.20 | -0.31 | -0.20 | -0.19 |
| Revenue Estimate | 200K | 500K | 1.10M | 5.50M |
| Revenue Actual | 2.46M | 197K | 601K | 1.40M |
| 季度 | 2023 年第三季度 | 2023 年第二季度 | 2023年第一季度 | 2022 年第四季度 |
|---|---|---|---|---|
| 每股收益估算 | -0.29 | -0.24 | -0.22 | -0.15 |
| 實際每股收益 | -0.20 | -0.31 | -0.20 | -0.19 |
| 收入估算 | 200 | 500K | 1.10 米 | 5.50 米 |
| 實際收入 | 2.46 億 | 197 K | 601K | 1.40 米 |
To track all earnings releases for Co-Diagnostics visit their earnings calendar here.
要追蹤Co-Diagnostics的所有業績，請在此處訪問他們的業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。